Is BAK or GEVO more undervalued in 2026?

CirclFi compares Braskem SA (BAK) and Gevo, Inc. (GEVO) using 13 institutional-grade valuation models. BAK has a Quality of Company score of 5.5/10 while GEVO scores 6.8/10.

Which is a better buy — BAK or GEVO?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do BAK and GEVO valuations compare?

BAK at $4.16 and GEVO at $1.86 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

BAK vs GEVO Valuation Comparison 2026 — Intrinsic Value Analysis

BAK

Industrial Organic Chemicals

Braskem SA

Quality

5.5

out of 10

Value Trap

SAFE

Price

$4.16

Last close

Models

6/13

Active

GEVO

Industrial Organic Chemicals

Gevo, Inc.

Quality

6.8

out of 10

Value Trap

LOW

Price

$1.86

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	BAK Fair Value	BAK Upside	GEVO Fair Value	GEVO Upside
Bayesian DCF	Intrinsic	$19.04	+357.6%	$0.31	-83.2%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$11.57	+178.1%	$3.26	+75.2%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for BAK vs GEVO — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BAK vs GEVO — Which Stock Is More Undervalued?

GEVO scores higher with a 6.8/10 quality rating vs BAK's 5.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Braskem SA (BAK) and Gevo, Inc. (GEVO) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BAK currently trades at $4.16 with a QOC of 5.5/10, while GEVO trades at $1.86 with a QOC of 6.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).